Physician profile
Robert Hooker
NPI 1265405765
$51,587.31
in general payments reported to CMS, 2019-2025
23 companies · $2,969 in 2025
The $2,969 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,021 · 2020: $487 · 2021: $1,061 · 2022: $2,659 · 2023: $30K · 2024: $12K · 2025: $2,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $5,565 · Food and Beverage: $2,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,500.00 |
| Travel and Lodging | $5,565.11 |
| Food and Beverage | $2,294.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragonix Technologies, INC. | $37,500.00 | 2023-2024 | Paragonix Sherpapak Cardiac Transport System, Sherpacool Box, Cts Canister Box |
| Transmedics, INC. | $4,950.25 | 2024-2025 | Organ Care System |
| Abbott Laboratories | $2,905.02 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic |
| Abiomed | $2,707.97 | 2019-2025 | Impella |
| Michigan Critical Care Consultants, INC. | $1,474.31 | 2019 | |
| Elutia, INC. | $372.43 | 2020-2022 | |
| Edwards Lifesciences Corporation | $349.12 | 2020-2024 | Mitris Resilia Mitral Valve, Konect Resilia |
| Atricure, INC. | $299.23 | 2019-2023 | |
| Becton, Dickinson and Company | $141.56 | 2022 | |
| Cvrx, INC. | $110.62 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $89.80 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $87.54 | 2019-2020 | |
| Medtronic, INC. | $84.65 | 2022-2025 | Mycarelink |
| Depuy Synthes Sales INC. | $83.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $82.26 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $81.32 | 2022-2024 | Pico |
| Janssen Pharmaceuticals, INC | $67.52 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $66.34 | 2023 | Assure Wcd |
| Davol INC. | $41.00 | 2022 | |
| Amgen INC. | $40.53 | 2023 | Repatha |
| Medtronic USA, INC. | $18.89 | 2020 | |
| Artivion, INC. | $18.54 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $14.59 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hooker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.